The authors highlighted their findings of significant cis-eSNPs that influence expression of GSTO2, but not GSTO1, which were previously implicated in AD risk[46,47], thereby implicating GSTO2 as the likely AD risk gene in this region. Here, GSTO2 is linked to Alzheimer disease.